With more than 200 mpox-related deaths reported globally, the EMA has approved Imvanex for adolescents aged 12-17 years.

Rwanda has launched the first mpox vaccination campaign in Africa, marking a significant step in the continent’s fight ...

Mpox — which causes mostly mild symptoms like fever and body aches, but can trigger serious cases with prominent blisters on the face, hands, chest and genitals — had been spreading mostly undetected ...

The African health agency says that Rwanda has started a vaccination campaign against mpox with 1,000 doses it obtained from ...

LONDON (Reuters) -Bavarian Nordic said on Thursday its mpox vaccine was approved by the EU's drug regulator for use in ...

Rwanda has initiated a vaccination campaign against mpox with 1,000 doses from Nigeria. The campaign, targeting high-risk ...

Mpox is not under control in Africa, the Africa Centres for Disease Control and Prevention (CDC) said on Thursday. Within a ...

Mpox vaccines have been administered in Africa for the first time, with several hundred high-risk individuals vaccinated in ...

The mpox outbreak in Africa is still not under control, the Africa Centres for Disease Control and Prevention (Africa CDC) ...

Lessons learned from the COVID pandemic have left the world in a much better position to tackle the current mpox epidemic ...

Overall, Congo has more than 21,000 of the 25,093 confirmed and suspected mpox cases in Africa this year, according to WHO’s ...